FIELD: smoking accessories.
SUBSTANCE: group of inventions relates to a water-soluble pressed lozenge for nicotine cravings relief and a method for production thereof. Water-soluble pressed nicotine lozenge for oral administration comprises a first module and a second module, the first and second modules are connected by crimping, first and second modules are formed by a plurality of compacted particles, the first module is a resorption module containing at least one sugar alcohol in an amount of at least 50 wt.% of first module, and the second module is an FDT module containing at least one sugar alcohol in an amount of at least 50 wt.% of second module, and nicotine, where the second module contains a baking powder, where the second module contains nicotine in amount of 0.2 to 5 wt.% of second module, where the leavening agent contains a superdisintegrant, where the superdisintegrant includes cross-linked polymers, where the amount of superdisintegrant is from 1 to 14 wt.% of second module, where the first module does not contain nicotine and where the first module contains a flavouring agent. Method for production of water-soluble pressed nicotine lozenge for oral administration includes the following stages: providing a first powder composition and a second powder composition, where the first powder composition contains at least one sugar alcohol in an amount of at least 50 wt.% of first powder composition, second powder composition contains at least one sugar alcohol in an amount of at least 50 wt.% of a second powder composition, and nicotine; pressing the first powder composition and the second powder composition to produce a modular lozenge, combined by pressing with the FDT-module, where the second powder composition contains a baking powder, where the second powder composition contains nicotine in amount of 0.2 to 5 wt.% of second powder composition, where baking powder contains superdisintegrant, where the superdisintegrant includes cross-linked polymers, where the amount of superdisintegrant is from 1 to 14 wt.% of second module, where the first module does not contain nicotine and where the first module contains a flavouring agent. Water-soluble pressed nicotine lozenge for oral administration comprises a first module and a second module, the first and second modules are combined by pressing, first and second modules are formed by a plurality of compressed particles, the first module is a modular lozenge and the second module is an FDT module containing nicotine, where the second module contains a baking powder, where the second module contains nicotine in amount of 0.2 to 5 wt.% of second module, where baking powder contains superdisintegrant, where superdisintegrant includes cross-linked polymers, where the amount of superdisintegrant ranges from 1 to 14 wt.% of second module, where the first module does not contain nicotine and where the first module contains a flavouring agent.
EFFECT: above-described compositions effectively relieve craving for nicotine, mask burning sensation.
80 cl, 1 dwg, 13 tbl, 70 ex
Title | Year | Author | Number |
---|---|---|---|
ION EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE POLYMERS | 2020 |
|
RU2812603C1 |
SOLID ORAL NICOTINE COMPOSITION | 2018 |
|
RU2786451C2 |
CARRIER FOR ORAL DELIVERY | 2016 |
|
RU2738205C1 |
MULTICOMPONENT ORAL DOSAGE FORM WITH ORGANOLEPTIC PROPERTIES | 2010 |
|
RU2490010C2 |
FILMS, DISSOLVING IN MOUTH CAVITY | 2004 |
|
RU2351315C2 |
PRODUCT IN FORM OF SACHET WITH LIQUID COMPOSITION OF FLAVOURING ADDITIVE | 2020 |
|
RU2818242C2 |
ORAL DOSAGE FORM CONTAINING OUTER COATING FOR FAST RELEASE | 2017 |
|
RU2789054C2 |
SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
NICOTINE SACHET PRODUCT | 2020 |
|
RU2819587C2 |
NICOTINE PHARMACEUTICAL FORM | 2013 |
|
RU2625836C2 |
Authors
Dates
2024-09-02—Published
2020-04-17—Filed